Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain

Sigma-1 receptors (S1R) and sigma-2 receptors (S2R) may modulate nociception without the liabilities of opioids, offering a promising therapeutic target to treat pain. The purpose of this study was to investigate the in vivo analgesic and anti-allodynic activity of two novel sigma receptor antagonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirino, Thomas J., Eans, Shainnel O., Medina, Jessica M., Wilson, Lisa L., Mottinelli, Marco, Intagliata, Sebastiano, McCurdy, Christopher R., McLaughlin, Jay P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586922/
https://www.ncbi.nlm.nih.gov/pubmed/31258480
http://dx.doi.org/10.3389/fphar.2019.00678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586922/
https://www.ncbi.nlm.nih.gov/pubmed/31258480
http://dx.doi.org/10.3389/fphar.2019.00678

Ejemplares similares